Prof. Dr. Altunta\u015f, 21 Nisan Akut Miyeloid L\u00f6semi (AML) Fark\u0131ndal\u0131k G\u00fcn\u00fc dolay\u0131s\u0131yla AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, kan kanseri t\u00fcr\u00fc olan bu hastal\u0131\u011fa kar\u015f\u0131 toplumda fark\u0131ndal\u0131k olu\u015fturmaya \u00e7al\u0131\u015ft\u0131klar\u0131n\u0131 vurgulad\u0131.<\/p>\n
Akut l\u00f6semilerin eri\u015fkinlerde daha s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirten Altunta\u015f, “Akut l\u00f6semide kemik ili\u011finde anormal h\u00fccreler \u00e7o\u011falarak, normal h\u00fccreleri bask\u0131lar ve bu nedenle normal h\u00fccreler i\u015flevlerini yerine getirememektedir. Bunun sonucunda da kans\u0131zl\u0131k olu\u015fur.” bilgisini payla\u015ft\u0131.<\/p>\n
Ayn\u0131 zamanda beyaz kan h\u00fccrelerinde d\u00fc\u015f\u00fckl\u00fc\u011f\u00fcn ya\u015fand\u0131\u011f\u0131n\u0131, ki\u015filerin bu nedenle enfeksiyonlara \u00e7ok yatk\u0131n hale geldi\u011fini, ciltte morarma \u015feklinde de g\u00f6r\u00fclen kanama e\u011filimlerinin de g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc anlatan Altunta\u015f, “D\u00fc\u015fmeyen y\u00fcksek ate\u015f, kanama, ciddi halsizlik ile tutulum olan organ\u0131n yetmezli\u011fi AML hastalar\u0131nda en s\u0131k kar\u015f\u0131la\u015ft\u0131\u011f\u0131m\u0131z belirtiler. A\u00e7\u0131klanamayan bu t\u00fcr bulgular\u0131n varl\u0131\u011f\u0131nda ki\u015filere mutlaka bir hekime ba\u015fvurmalar\u0131n\u0131 \u00f6neriyoruz.” diye konu\u015ftu.<\/p>\n
AML’nin \u00f6zellikle 60 ya\u015f\u0131n \u00fczerinde daha s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktaran Altunta\u015f, \u015funlar\u0131 kaydetti:<\/p>\n “T\u00fcrkiye’de hastal\u0131\u011f\u0131n g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 40 ya\u015f \u00fczerinde art\u0131yor. Erkeklerde kad\u0131nlara g\u00f6re 2-3 kat daha fazla g\u00f6r\u00fcl\u00fcyor. Genel olarak g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 100 binde 1 ile 100 binde 10 aras\u0131nda de\u011fi\u015fiyor. Yani ortalama 100 bin n\u00fcfusta yakla\u015f\u0131k 3 yeni vaka g\u00f6r\u00fclebiliyor. \u00dclkemizin n\u00fcfusu dikkate al\u0131nd\u0131\u011f\u0131nda y\u0131lda yakla\u015f\u0131k 2 bin-2 bin 500 civar\u0131nda ki\u015fiye akut l\u00f6semi te\u015fhisi konulmas\u0131 bekleniyor.”<\/p>\n Prof. Dr. Altunta\u015f, “Akut l\u00f6semi en a\u011f\u0131r ve agresif seyirli hastal\u0131klardan biridir. Fakat \u00e7ok \u015f\u00fck\u00fcr g\u00fcn\u00fcm\u00fczde geli\u015ftirilen tan\u0131, tedavi ve takip y\u00f6ntemleri sayesinde, akut l\u00f6semide sa\u011f kal\u0131m s\u00fcreleri uzad\u0131. 30 y\u0131ll\u0131k ve son 10 y\u0131ll\u0131k s\u00fcre\u00e7le k\u0131yaslad\u0131\u011f\u0131m\u0131zda akut l\u00f6semi hastalar\u0131nda \u00f6m\u00fcr s\u00fcresi 3 kat artt\u0131.” dedi.<\/p>\n Bat\u0131 \u00fclkeleri verilerine g\u00f6re, ge\u00e7mi\u015fte y\u00fczde 10’un alt\u0131nda olan AML sa\u011f kal\u0131m oranlar\u0131n\u0131n y\u00fczde 30’un \u00fczerine \u00e7\u0131kt\u0131\u011f\u0131na dikkati \u00e7eken Altunta\u015f, iyi seyirli alt gruplarda ise bu oran\u0131n y\u00fczde 60’\u0131 ge\u00e7ti\u011fini s\u00f6yledi.<\/p>\n Altunta\u015f, akut l\u00f6semilerin tan\u0131 ve tedavisinde art\u0131k imm\u00fcnolojik, molek\u00fcler ve h\u00fccre bazl\u0131 y\u00f6ntemlerin kullan\u0131ld\u0131\u011f\u0131n\u0131, bunun \u00f6m\u00fcr s\u00fcresinin uzamas\u0131ndaki en \u00f6nemli etken oldu\u011funu belirterek s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<\/p>\n “Akut l\u00f6semi tedavisinde art\u0131k bir nevi hastal\u0131\u011f\u0131n parmak izini \u00e7\u0131kar\u0131yoruz ve bunu tan\u0131, tedavi ve takipte kullan\u0131yoruz. Hedefli tedaviler dedi\u011fimiz bireyselle\u015ftirilmi\u015f tedaviler, sa\u011f kal\u0131m s\u00fcrelerinin uzamas\u0131n\u0131 sa\u011fl\u0131yor. \u00d6rne\u011fin, hastada akut l\u00f6semiye neden olan bir gen tespit etti\u011fimizde o geni durdurmaya, yaratt\u0131\u011f\u0131 olumsuz etkileri \u00f6nlemeye odaklan\u0131yoruz ve buna y\u00f6nelik bireyselle\u015ftirilmi\u015f tedavileri devreye al\u0131yoruz.<\/p>\n B\u00f6ylelikle hastal\u0131\u011f\u0131 uzun d\u00f6nem kontrol etmek m\u00fcmk\u00fcn oluyor. Gururla s\u00f6yleyebiliriz, bir\u00e7ok ilk \u00fclkemizde de uygulan\u0131yor, uluslararas\u0131 akredite k\u00f6k h\u00fccre nakli merkezlerimiz var. Yurt d\u0131\u015f\u0131ndan \u00f6nemli say\u0131da hasta da tedavi i\u00e7in \u00fclkemize geliyor.”<\/p>\n T\u00fcrkiye’nin k\u00f6k h\u00fccre naklinde de Avrupa’n\u0131n y\u00fckselen y\u0131ld\u0131z\u0131 oldu\u011funu, geli\u015fmi\u015f \u00fclkelerle benzer oranda ilerledi\u011fini vurgulayan Altunta\u015f, “L\u00f6semi tedavisinde \u00fclkemizde ula\u015famad\u0131\u011f\u0131m\u0131z yenilik\u00e7i bir yakla\u015f\u0131m yok. D\u00fcnyada ruhsat alm\u0131\u015f, kullan\u0131m izni olan her ilaca \u00fclkemizde de ula\u015fmak m\u00fcmk\u00fcn.” ifadesini kulland\u0131.<\/p>\n T\u00fcrkiye’de ayn\u0131 zamanda kanser tedavisiyle ilgili klinik \u00e7al\u0131\u015fmalar\u0131n s\u00fcrd\u00fc\u011f\u00fcne i\u015faret eden Prof. Dr. Altunta\u015f, akut l\u00f6semi hastalar\u0131n\u0131n bu \u00e7al\u0131\u015fmalara kat\u0131l\u0131m sa\u011flamas\u0131yla yenilik\u00e7i tedavilere de ula\u015fabilece\u011fine dikkati \u00e7ekti.<\/p>\n Altunta\u015f, k\u00f6k h\u00fccre naklinin akut l\u00f6semide \u00f6nemli bir tedavi se\u00e7ene\u011fi oldu\u011funun alt\u0131n\u0131 \u00e7izerek, “Fakat k\u00f6k h\u00fccre naklinde uygun verici bulunamayan hastalar\u0131m\u0131z da pani\u011fe kap\u0131lmamal\u0131. Bu tedavinin bitti\u011fi anlam\u0131na gelmemektedir, yenilik\u00e7i yakla\u015f\u0131mlarla klinik ara\u015ft\u0131rmalara kat\u0131l\u0131mla tedavi ba\u015far\u0131 \u015fans\u0131 her zaman var.” de\u011ferlendirmesinde bulundu.<\/p>\n Akut l\u00f6semi ve di\u011fer t\u00fcm kanser t\u00fcrlerinin tedavisinde psikolojik deste\u011fin \u00f6nemine de vurgu yapan Altunta\u015f, “Psikolojik, manevi ve sosyal destek hastalar\u0131n tedaviye uyumunu, kendine g\u00fcvenini ve ya\u015fam kalitesini art\u0131r\u0131yor. Bu nedenle akut l\u00f6semi hastalar\u0131nda s\u00f6z konusu desteklerin uzun soluklu olarak s\u00fcrd\u00fcr\u00fclmesi laz\u0131m.” dedi.<\/p>\n Prof. Dr. Altunta\u015f, hastanede hastalar i\u00e7in d\u00fczenli olarak \u00e7e\u015fitli at\u00f6lyeler d\u00fczenlediklerini, hastal\u0131\u011f\u0131 yenen ki\u015filerle hastalar\u0131 belli d\u00f6nemlerde bir araya getirdiklerini dile getirerek, “Akut l\u00f6semi kontrol edilebilir, tedavi edilebilir bir hastal\u0131k. Ki\u015filer bu hastal\u0131\u011f\u0131 yenip i\u015f kurabilir, evlenebilir, \u00fcniversiteyi bitirebilir yani normal hayat\u0131n\u0131 s\u00fcrd\u00fcrebilir. T\u00fcm hastalar\u0131m\u0131z buna inanmal\u0131.” diye konu\u015ftu.<\/p>\n![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/a54ea27f-6036-4f79-88c6-6bc9ba19a35d\/08_Nisan%2F09%20mart%2F14%2FAA-30922097.jpg\"\/)
Foto\u011fraf:\u00a0\u00d6zge Elif K\u0131z\u0131l\/AA<\/em><\/p>\n“T\u00fcrkiye’de y\u0131lda yakla\u015f\u0131k 2 bin 500 ki\u015fiye akut l\u00f6semi te\u015fhisi konuluyor”<\/h3>\n
“\u00d6m\u00fcr s\u00fcresi 3 kat artt\u0131”<\/h3>\n
“Hastal\u0131\u011f\u0131n parmak izini \u00e7\u0131kar\u0131yoruz”<\/h3>\n
“D\u00fcnyada kullan\u0131m izni olan her ilaca \u00fclkemizde de ula\u015fmak m\u00fcmk\u00fcn”<\/h3>\n
“Psikolojik, manevi ve sosyal destek tedaviye uyumu art\u0131r\u0131yor”<\/h3>\n